Parametric Portfolio Associates’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.43M Buy
157,013
+56,724
+57% +$437K ﹤0.01% 2599
2021
Q4
$704K Sell
100,289
-18,651
-16% -$195K ﹤0.01% 2933
2021
Q3
$1.36M Buy
118,940
+6,276
+6% +$91.7K ﹤0.01% 2660
2021
Q2
$1.8M Buy
112,664
+788
+0.7% +$13.5K ﹤0.01% 2495
2021
Q1
$2M Buy
111,876
+5,981
+6% +$103K ﹤0.01% 2777
2020
Q4
$1.43M Buy
105,895
+31,310
+42% +$378K ﹤0.01% 2860
2020
Q3
$878K Sell
74,585
-17,814
-19% -$217K ﹤0.01% 3000
2020
Q2
$1.36M Buy
92,399
+31,637
+52% +$468K ﹤0.01% 2742
2020
Q1
$820K Sell
60,762
-110,657
-65% -$2.1M ﹤0.01% 2907
2019
Q4
$4.14M Buy
171,419
+40,986
+31% +$849K ﹤0.01% 2198
2019
Q3
$2.51M Buy
130,433
+61,189
+88% +$1.4M ﹤0.01% 2503
2019
Q2
$2.05M Sell
69,244
-5,107
-7% -$197K ﹤0.01% 2659
2019
Q1
$3.53M Buy
74,351
+6,463
+10% +$284K ﹤0.01% 2252
2018
Q4
$2.45M Sell
67,888
-1,147
-2% -$53.8K ﹤0.01% 2446
2018
Q3
$4.25M Sell
69,035
-11,586
-14% -$745K ﹤0.01% 2154
2018
Q2
$5.45M Buy
80,621
+703
+0.9% +$39.3K 0.01% 1893
2018
Q1
$4.34M Sell
79,918
-3,698
-4% -$207K ﹤0.01% 2016
2017
Q4
$5M Sell
83,616
-7,606
-8% -$461K 0.01% 1920
2017
Q3
$4.43M Buy
91,222
+17,624
+24% +$962K ﹤0.01% 1946
2017
Q2
$3.87M Buy
73,598
+5,200
+8% +$242K ﹤0.01% 2006
2017
Q1
$3.1M Buy
68,398
+3,739
+6% +$167K ﹤0.01% 2153
2016
Q4
$2.45M Buy
64,659
+2,988
+5% +$113K ﹤0.01% 2237
2016
Q3
$2.33M Buy
61,671
+14,677
+31% +$324K ﹤0.01% 2238
2016
Q2
$827K Buy
46,994
+34,695
+282% +$562K ﹤0.01% 2953
2016
Q1
$150K Sell
12,299
-18,537
-60% -$293K ﹤0.01% 3804
2015
Q4
$751K Buy
30,836
+10,524
+52% +$246K ﹤0.01% 2995
2015
Q3
$360K Sell
20,312
-1,640
-7% -$29.7K ﹤0.01% 2882
2015
Q2
$387K Buy
21,952
+14,629
+200% +$268K ﹤0.01% 3427
2015
Q1
$230K Sell
7,323
-2,987
-29% -$86.6K ﹤0.01% 3694
2014
Q4
$301K Buy
+10,310
New +$261K ﹤0.01% 3561

Other funds holding AERI